Maravai LifeSciences (NASDAQ:MRVI) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.05) by 120 percent. This is a 112.5 percent increase over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $65.837 million which beat the analyst consensus estimate of $53.046 million by 24.11 percent. This is a 40.53 percent increase over sales of $46.850 million the same period last year.